137 related articles for article (PubMed ID: 19034754)
1. Quetiapine in patients with borderline personality disorder: an open-label trial.
Adityanjee ; Romine A; Brown E; Thuras P; Lee S; Schulz SC
Ann Clin Psychiatry; 2008; 20(4):219-26. PubMed ID: 19034754
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
Lee KU; Jeon YW; Lee HK; Jun TY
Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.
Van den Eynde F; Senturk V; Naudts K; Vogels C; Bernagie K; Thas O; van Heeringen C; Audenaert K
J Clin Psychopharmacol; 2008 Apr; 28(2):147-55. PubMed ID: 18344724
[TBL] [Abstract][Full Text] [Related]
4. Comparison of low and moderate dosages of extended-release quetiapine in borderline personality disorder: a randomized, double-blind, placebo-controlled trial.
Black DW; Zanarini MC; Romine A; Shaw M; Allen J; Schulz SC
Am J Psychiatry; 2014 Nov; 171(11):1174-82. PubMed ID: 24968985
[TBL] [Abstract][Full Text] [Related]
5. Quetiapine for the treatment of borderline personality disorder; an open-label study.
Perrella C; Carrus D; Costa E; Schifano F
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):158-63. PubMed ID: 17045720
[TBL] [Abstract][Full Text] [Related]
6. An open trial of valproate in borderline personality disorder.
Stein DJ; Simeon D; Frenkel M; Islam MN; Hollander E
J Clin Psychiatry; 1995 Nov; 56(11):506-10. PubMed ID: 7592502
[TBL] [Abstract][Full Text] [Related]
7. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
Katzman MA; Vermani M; Jacobs L; Marcus M; Kong B; Lessard S; Galarraga W; Struzik L; Gendron A
J Anxiety Disord; 2008 Dec; 22(8):1480-6. PubMed ID: 18455360
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H
J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
[TBL] [Abstract][Full Text] [Related]
9. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.
Berger GE; Proffitt TM; McConchie M; Kerr M; Markulev C; Yuen HP; O'Donnell C; Lubman D; Polari A; Wood S; Amminger PG; McGorry PD
J Clin Psychiatry; 2008 Nov; 69(11):1702-14. PubMed ID: 19036233
[TBL] [Abstract][Full Text] [Related]
10. [Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder].
György B; Robert K; László C; Andrea J;
Neuropsychopharmacol Hung; 2008 Dec; 10(5):293-303. PubMed ID: 19419015
[TBL] [Abstract][Full Text] [Related]
11. Preliminary evidence of improvement of depressive symptoms but not impulsivity in cluster B personality disorder patients treated with quetiapine: an open label trial.
Roepke S; Merkl A; Dams A; Ziegenhorn A; Anghelescu IG; Heuser I; Lammers CH
Pharmacopsychiatry; 2008 Sep; 41(5):176-81. PubMed ID: 18763219
[TBL] [Abstract][Full Text] [Related]
12. Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target.
Villeneuve E; Lemelin S
J Clin Psychiatry; 2005 Oct; 66(10):1298-303. PubMed ID: 16259544
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.
Bellino S; Paradiso E; Bogetto F
J Clin Psychiatry; 2006 Jul; 67(7):1042-6. PubMed ID: 16889446
[TBL] [Abstract][Full Text] [Related]
14. Quetiapine for the treatment of cocaine dependence: an open-label trial.
Kennedy A; Wood AE; Saxon AJ; Malte C; Harvey M; Jurik J; Kilzieh N; Lofgreen C; Tapp A
J Clin Psychopharmacol; 2008 Apr; 28(2):221-4. PubMed ID: 18344735
[TBL] [Abstract][Full Text] [Related]
15. Quetiapine treatment and improved cognitive functioning in borderline personality disorder.
Van den Eynde F; De Saedeleer S; Naudts K; Day J; Vogels C; van Heeringen C; Audenaert K
Hum Psychopharmacol; 2009 Dec; 24(8):646-9. PubMed ID: 19946934
[TBL] [Abstract][Full Text] [Related]
16. [Abuse of quetiapine. Two addicted patients with borderline personality disorder].
Galyuk TM; de Backer G; de Jong CA; Beers E; Loonen AJ
Ned Tijdschr Geneeskd; 2009 Apr; 153(14):674-6. PubMed ID: 19425328
[No Abstract] [Full Text] [Related]
17. Yi-gan san for the treatment of borderline personality disorder: an open-label study.
Miyaoka T; Furuya M; Yasuda H; Hayashia M; Inagaki T; Horiguchi J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):150-4. PubMed ID: 17765378
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of rapid dose administration of quetiapine in bipolar mania.
Hatim A; Habil H; Jesjeet SG; Low CC; Joseph J; Jambunathan ST; Zuraida NZ
Hum Psychopharmacol; 2006 Jul; 21(5):313-8. PubMed ID: 16856220
[TBL] [Abstract][Full Text] [Related]
19. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia.
Perez V; Cañas F; Tafalla M;
Int Clin Psychopharmacol; 2008 May; 23(3):138-49. PubMed ID: 18408528
[TBL] [Abstract][Full Text] [Related]
20. De novo induction of obsessive-compulsive symptoms with quetiapine in a patient with borderline personality disorder.
Alexander J
Aust N Z J Psychiatry; 2009 Dec; 43(12):1185. PubMed ID: 20001420
[No Abstract] [Full Text] [Related]
[Next] [New Search]
